CIK 0001087294
- Non-accelerated filer
- Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- Operating
- EIN
- 621765329
- Phone
- +1 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Open-market buy Chairman and CEO bought 1,682 shares at an average $6.36 ($10,690)
- 4 Open-market buy Director bought 1,682 shares at an average $6.36 ($10,690)
- 4 Shares withheld for taxes SVP and Chief Development Off. gave up 1,850 shares (to pay taxes)
- 4 Open-market buy Director bought 6,695 shares at an average $6.27 ($42,007)
- 4 Open-market buy Director bought 3,846 shares at an average $5.87 ($22,578)
- 4 Open-market buy Director bought 3,708 shares at an average $6.15 ($22,790)
- 4 Open-market buy Director bought 1,526 shares at an average $6.13 ($9,351)
- 4 Open-market buy Chairman and CEO bought 1,526 shares at an average $6.13 ($9,351)
- 4 Open-market buy Director bought 3,166 shares at an average $6.11 ($19,336)
- 4 Open-market buy Director bought 1,596 shares at an average $6.12 ($9,771)
- 4 Grant or award Chief Financial Officer acquired 2,500 shares (grant or award)
- 4 Grant or award VP and Chief Compliance Office acquired 3,000 shares (grant or award)
- 4 Grant or award Sr VP/Chief Commercial Officer acquired 5,000 shares (grant or award)
- 4 Grant or award SVP and Chief Development Off. acquired 25,000 shares (grant or award)
- 4 Grant or award Chairman and CEO acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
Page 16 of 26 · 512 filings